Skip to content

Study on Chandraprabha Vati and Hinguadi guda Varti in the management of pain of menstruation in reproductive age females

Comparative study of efficacy on Chandraprabha Vati and Hinguadi Cuda Varti in the management of Kashtartava in reproductive age females

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096613
Enrollment
86
Registered
2025-10-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

POSTGRADUATE UNIVERSITY OF INDIGENOUS MEDICINE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age group between 16-36 years suffering from painful menstruation for last three consecutive regular menstrual cycles. 21-35 days of length with normal bleeding and who are diagnosed as endometriosis previously will be included

Exclusion criteria

Exclusion criteria: Patients below 16 years and above 36 years patients with chronic illness, patients with intrauterine contraceptive devices, patients with menorrhagia uterine pathology fibroid, ovarian cyst, PID, Malignancy hemorrhagic cyst pregnant and lactating women etc will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
To compare the therapeutic effect of Chandraprabha vati and Hinguadi guda varti in the management of kashta artavaTimepoint: 12 weeks

Secondary

MeasureTime frame
To study the Ayurveda pathogenesis of Kashtartava. To evaluate the efficacy of Chandraprabha vati & Hinguadi guda varti on signs & symptoms of Kashtartava Timepoint: 12weeks

Countries

Sri Lanka

Contacts

Public ContactDr U P P WIJETHUNGA

BANDARANAYAKA MEMORIAL AYURVEDA RESEARCH INSTITUTE

sabinaurs@gmail.com0094718047368

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026